nodes	percent_of_prediction	percent_of_DWPC	metapath
Disopyramide—KCND2—epilepsy syndrome	0.245	0.574	CbGaD
Disopyramide—CHRM3—epilepsy syndrome	0.0673	0.158	CbGaD
Disopyramide—CHRM1—epilepsy syndrome	0.0627	0.147	CbGaD
Disopyramide—CHRM2—epilepsy syndrome	0.0512	0.12	CbGaD
Disopyramide—SCN5A—Oxcarbazepine—epilepsy syndrome	0.0482	0.144	CbGbCtD
Disopyramide—SCN5A—Fosphenytoin—epilepsy syndrome	0.0421	0.126	CbGbCtD
Disopyramide—SCN5A—Lamotrigine—epilepsy syndrome	0.0352	0.105	CbGbCtD
Disopyramide—SCN5A—Rufinamide—epilepsy syndrome	0.0311	0.0927	CbGbCtD
Disopyramide—SCN5A—Carbamazepine—epilepsy syndrome	0.0303	0.0903	CbGbCtD
Disopyramide—SCN5A—Phenytoin—epilepsy syndrome	0.0272	0.081	CbGbCtD
Disopyramide—SCN5A—Zonisamide—epilepsy syndrome	0.0224	0.0668	CbGbCtD
Disopyramide—SCN5A—Topiramate—epilepsy syndrome	0.0163	0.0487	CbGbCtD
Disopyramide—SLC22A1—Midazolam—epilepsy syndrome	0.0158	0.0471	CbGbCtD
Disopyramide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00586	0.0175	CbGbCtD
Disopyramide—CYP3A4—Trimethadione—epilepsy syndrome	0.00544	0.0162	CbGbCtD
Disopyramide—CYP3A4—Felbamate—epilepsy syndrome	0.00544	0.0162	CbGbCtD
Disopyramide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00512	0.0153	CbGbCtD
Disopyramide—CYP3A4—Clonazepam—epilepsy syndrome	0.00463	0.0138	CbGbCtD
Disopyramide—CYP3A4—Clobazam—epilepsy syndrome	0.00444	0.0132	CbGbCtD
Disopyramide—CYP3A4—Rufinamide—epilepsy syndrome	0.00377	0.0113	CbGbCtD
Disopyramide—CYP3A4—Carbamazepine—epilepsy syndrome	0.00368	0.011	CbGbCtD
Disopyramide—CYP3A4—Primidone—epilepsy syndrome	0.00343	0.0102	CbGbCtD
Disopyramide—CYP3A4—Phenytoin—epilepsy syndrome	0.0033	0.00984	CbGbCtD
Disopyramide—CYP3A4—Propofol—epilepsy syndrome	0.00308	0.00918	CbGbCtD
Disopyramide—CYP3A4—Phenobarbital—epilepsy syndrome	0.00294	0.00877	CbGbCtD
Disopyramide—CYP3A4—Acetazolamide—epilepsy syndrome	0.00294	0.00877	CbGbCtD
Disopyramide—CYP3A4—Midazolam—epilepsy syndrome	0.0029	0.00865	CbGbCtD
Disopyramide—CYP3A4—Diazepam—epilepsy syndrome	0.00279	0.00831	CbGbCtD
Disopyramide—CYP3A4—Zonisamide—epilepsy syndrome	0.00272	0.00811	CbGbCtD
Disopyramide—CYP3A4—Valproic Acid—epilepsy syndrome	0.0022	0.00655	CbGbCtD
Disopyramide—CYP3A4—Topiramate—epilepsy syndrome	0.00198	0.00591	CbGbCtD
Disopyramide—KCND2—hindbrain—epilepsy syndrome	0.00181	0.0695	CbGeAlD
Disopyramide—KCND3—hindbrain—epilepsy syndrome	0.00158	0.0606	CbGeAlD
Disopyramide—SLC22A1—ganglion—epilepsy syndrome	0.00104	0.0401	CbGeAlD
Disopyramide—KCND2—brainstem—epilepsy syndrome	0.00104	0.0398	CbGeAlD
Disopyramide—KCND2—forebrain—epilepsy syndrome	0.001	0.0384	CbGeAlD
Disopyramide—KCND2—telencephalon—epilepsy syndrome	0.00092	0.0353	CbGeAlD
Disopyramide—KCND3—brainstem—epilepsy syndrome	0.000904	0.0347	CbGeAlD
Disopyramide—KCND3—forebrain—epilepsy syndrome	0.000872	0.0335	CbGeAlD
Disopyramide—KCND3—telencephalon—epilepsy syndrome	0.000802	0.0308	CbGeAlD
Disopyramide—KCND2—medulla oblongata—epilepsy syndrome	0.000723	0.0278	CbGeAlD
Disopyramide—KCND2—midbrain—epilepsy syndrome	0.000661	0.0254	CbGeAlD
Disopyramide—KCND2—spinal cord—epilepsy syndrome	0.000644	0.0248	CbGeAlD
Disopyramide—KCND3—midbrain—epilepsy syndrome	0.000576	0.0221	CbGeAlD
Disopyramide—KCND2—head—epilepsy syndrome	0.000573	0.022	CbGeAlD
Disopyramide—KCND2—nervous system—epilepsy syndrome	0.000543	0.0209	CbGeAlD
Disopyramide—KCND2—central nervous system—epilepsy syndrome	0.000523	0.0201	CbGeAlD
Disopyramide—KCND2—cerebellum—epilepsy syndrome	0.000511	0.0196	CbGeAlD
Disopyramide—KCND3—head—epilepsy syndrome	0.000499	0.0192	CbGeAlD
Disopyramide—KCND3—nervous system—epilepsy syndrome	0.000473	0.0182	CbGeAlD
Disopyramide—KCND3—central nervous system—epilepsy syndrome	0.000456	0.0175	CbGeAlD
Disopyramide—CHRM2—forebrain—epilepsy syndrome	0.000446	0.0171	CbGeAlD
Disopyramide—KCND3—cerebellum—epilepsy syndrome	0.000445	0.0171	CbGeAlD
Disopyramide—SLC22A1—forebrain—epilepsy syndrome	0.000438	0.0168	CbGeAlD
Disopyramide—KCND2—brain—epilepsy syndrome	0.000415	0.0159	CbGeAlD
Disopyramide—CHRM2—telencephalon—epilepsy syndrome	0.00041	0.0157	CbGeAlD
Disopyramide—CHRM1—forebrain—epilepsy syndrome	0.000406	0.0156	CbGeAlD
Disopyramide—SLC22A1—telencephalon—epilepsy syndrome	0.000403	0.0155	CbGeAlD
Disopyramide—CHRM1—telencephalon—epilepsy syndrome	0.000373	0.0143	CbGeAlD
Disopyramide—CHRM3—forebrain—epilepsy syndrome	0.000363	0.0139	CbGeAlD
Disopyramide—KCND3—brain—epilepsy syndrome	0.000362	0.0139	CbGeAlD
Disopyramide—CHRM3—telencephalon—epilepsy syndrome	0.000334	0.0128	CbGeAlD
Disopyramide—Fesoterodine—CHRM3—epilepsy syndrome	0.000315	0.104	CrCbGaD
Disopyramide—ORM1—spinal cord—epilepsy syndrome	0.000308	0.0118	CbGeAlD
Disopyramide—SCN5A—head—epilepsy syndrome	0.0003	0.0115	CbGeAlD
Disopyramide—Fesoterodine—CHRM1—epilepsy syndrome	0.000294	0.0967	CrCbGaD
Disopyramide—SCN5A—nervous system—epilepsy syndrome	0.000284	0.0109	CbGeAlD
Disopyramide—SCN5A—central nervous system—epilepsy syndrome	0.000274	0.0105	CbGeAlD
Disopyramide—ORM1—nervous system—epilepsy syndrome	0.000259	0.00997	CbGeAlD
Disopyramide—CHRM2—head—epilepsy syndrome	0.000255	0.0098	CbGeAlD
Disopyramide—SLC22A1—head—epilepsy syndrome	0.000251	0.00963	CbGeAlD
Disopyramide—ORM1—central nervous system—epilepsy syndrome	0.00025	0.0096	CbGeAlD
Disopyramide—CHRM2—nervous system—epilepsy syndrome	0.000242	0.00929	CbGeAlD
Disopyramide—Fesoterodine—CHRM2—epilepsy syndrome	0.00024	0.0789	CrCbGaD
Disopyramide—SLC22A1—nervous system—epilepsy syndrome	0.000238	0.00913	CbGeAlD
Disopyramide—Methadyl Acetate—OPRM1—epilepsy syndrome	0.000237	0.078	CrCbGaD
Disopyramide—CHRM2—central nervous system—epilepsy syndrome	0.000233	0.00895	CbGeAlD
Disopyramide—CHRM1—head—epilepsy syndrome	0.000232	0.00892	CbGeAlD
Disopyramide—SLC22A1—central nervous system—epilepsy syndrome	0.000229	0.00879	CbGeAlD
Disopyramide—CHRM1—nervous system—epilepsy syndrome	0.00022	0.00846	CbGeAlD
Disopyramide—SCN5A—brain—epilepsy syndrome	0.000217	0.00835	CbGeAlD
Disopyramide—CHRM1—central nervous system—epilepsy syndrome	0.000212	0.00815	CbGeAlD
Disopyramide—CHRM3—head—epilepsy syndrome	0.000208	0.00799	CbGeAlD
Disopyramide—CHRM3—nervous system—epilepsy syndrome	0.000197	0.00757	CbGeAlD
Disopyramide—CHRM3—central nervous system—epilepsy syndrome	0.00019	0.00729	CbGeAlD
Disopyramide—Isopropamide—CHRM3—epilepsy syndrome	0.000186	0.0611	CrCbGaD
Disopyramide—CHRM2—brain—epilepsy syndrome	0.000185	0.0071	CbGeAlD
Disopyramide—SLC22A1—brain—epilepsy syndrome	0.000182	0.00698	CbGeAlD
Disopyramide—Isopropamide—CHRM1—epilepsy syndrome	0.000173	0.057	CrCbGaD
Disopyramide—Doxylamine—CHRM1—epilepsy syndrome	0.000173	0.057	CrCbGaD
Disopyramide—CHRM1—brain—epilepsy syndrome	0.000168	0.00647	CbGeAlD
Disopyramide—CHRM3—brain—epilepsy syndrome	0.000151	0.00579	CbGeAlD
Disopyramide—Tolterodine—CHRM3—epilepsy syndrome	0.000141	0.0463	CrCbGaD
Disopyramide—Tolterodine—CHRM1—epilepsy syndrome	0.000131	0.0432	CrCbGaD
Disopyramide—Dimetindene—CHRM2—epilepsy syndrome	0.000124	0.0407	CrCbGaD
Disopyramide—Dextropropoxyphene—OPRD1—epilepsy syndrome	0.000117	0.0384	CrCbGaD
Disopyramide—Fesoterodine—CYP2D6—epilepsy syndrome	0.00011	0.0361	CrCbGaD
Disopyramide—CYP3A4—nervous system—epilepsy syndrome	0.000108	0.00416	CbGeAlD
Disopyramide—Tolterodine—CHRM2—epilepsy syndrome	0.000107	0.0353	CrCbGaD
Disopyramide—CYP3A4—central nervous system—epilepsy syndrome	0.000104	0.00401	CbGeAlD
Disopyramide—Levomethadyl Acetate—OPRM1—epilepsy syndrome	0.000103	0.034	CrCbGaD
Disopyramide—Dextropropoxyphene—OPRM1—epilepsy syndrome	8.92e-05	0.0294	CrCbGaD
Disopyramide—Methadone—OPRD1—epilepsy syndrome	7.91e-05	0.026	CrCbGaD
Disopyramide—Fesoterodine—ABCB1—epilepsy syndrome	7.84e-05	0.0258	CrCbGaD
Disopyramide—Tolterodine—CYP2C19—epilepsy syndrome	6.61e-05	0.0218	CrCbGaD
Disopyramide—Tripelennamine—CYP2D6—epilepsy syndrome	6.15e-05	0.0202	CrCbGaD
Disopyramide—Methadone—OPRM1—epilepsy syndrome	6.05e-05	0.0199	CrCbGaD
Disopyramide—Tolterodine—CYP2D6—epilepsy syndrome	4.9e-05	0.0161	CrCbGaD
Disopyramide—Dizziness—Fosphenytoin—epilepsy syndrome	4.77e-05	0.000391	CcSEcCtD
Disopyramide—Dermatitis—Midazolam—epilepsy syndrome	4.76e-05	0.000391	CcSEcCtD
Disopyramide—Urticaria—Carbamazepine—epilepsy syndrome	4.76e-05	0.00039	CcSEcCtD
Disopyramide—Vomiting—Levetiracetam—epilepsy syndrome	4.75e-05	0.000389	CcSEcCtD
Disopyramide—Discomfort—Valproic Acid—epilepsy syndrome	4.74e-05	0.000389	CcSEcCtD
Disopyramide—Headache—Midazolam—epilepsy syndrome	4.74e-05	0.000388	CcSEcCtD
Disopyramide—Pruritus—Felbamate—epilepsy syndrome	4.74e-05	0.000388	CcSEcCtD
Disopyramide—Body temperature increased—Carbamazepine—epilepsy syndrome	4.73e-05	0.000388	CcSEcCtD
Disopyramide—Diarrhoea—Diazepam—epilepsy syndrome	4.73e-05	0.000388	CcSEcCtD
Disopyramide—Ill-defined disorder—Pregabalin—epilepsy syndrome	4.73e-05	0.000388	CcSEcCtD
Disopyramide—Rash—Levetiracetam—epilepsy syndrome	4.71e-05	0.000386	CcSEcCtD
Disopyramide—Dermatitis—Levetiracetam—epilepsy syndrome	4.7e-05	0.000386	CcSEcCtD
Disopyramide—Asthenia—Zonisamide—epilepsy syndrome	4.7e-05	0.000385	CcSEcCtD
Disopyramide—Agranulocytosis—Topiramate—epilepsy syndrome	4.69e-05	0.000385	CcSEcCtD
Disopyramide—Dry mouth—Valproic Acid—epilepsy syndrome	4.69e-05	0.000385	CcSEcCtD
Disopyramide—Headache—Levetiracetam—epilepsy syndrome	4.68e-05	0.000384	CcSEcCtD
Disopyramide—Angioedema—Pregabalin—epilepsy syndrome	4.65e-05	0.000382	CcSEcCtD
Disopyramide—Dizziness—Vigabatrin—epilepsy syndrome	4.65e-05	0.000381	CcSEcCtD
Disopyramide—Confusional state—Valproic Acid—epilepsy syndrome	4.64e-05	0.00038	CcSEcCtD
Disopyramide—Pruritus—Zonisamide—epilepsy syndrome	4.64e-05	0.00038	CcSEcCtD
Disopyramide—Flatulence—Gabapentin—epilepsy syndrome	4.6e-05	0.000377	CcSEcCtD
Disopyramide—Oedema—Valproic Acid—epilepsy syndrome	4.6e-05	0.000377	CcSEcCtD
Disopyramide—Urticaria—Lamotrigine—epilepsy syndrome	4.6e-05	0.000377	CcSEcCtD
Disopyramide—Bradycardia—Topiramate—epilepsy syndrome	4.6e-05	0.000377	CcSEcCtD
Disopyramide—Malaise—Pregabalin—epilepsy syndrome	4.59e-05	0.000377	CcSEcCtD
Disopyramide—Nausea—Propofol—epilepsy syndrome	4.59e-05	0.000376	CcSEcCtD
Disopyramide—Tension—Gabapentin—epilepsy syndrome	4.58e-05	0.000376	CcSEcCtD
Disopyramide—Vomiting—Fosphenytoin—epilepsy syndrome	4.58e-05	0.000376	CcSEcCtD
Disopyramide—Diarrhoea—Felbamate—epilepsy syndrome	4.58e-05	0.000376	CcSEcCtD
Disopyramide—Vertigo—Pregabalin—epilepsy syndrome	4.58e-05	0.000375	CcSEcCtD
Disopyramide—Body temperature increased—Lamotrigine—epilepsy syndrome	4.58e-05	0.000375	CcSEcCtD
Disopyramide—Dysgeusia—Gabapentin—epilepsy syndrome	4.57e-05	0.000375	CcSEcCtD
Disopyramide—Dizziness—Diazepam—epilepsy syndrome	4.57e-05	0.000375	CcSEcCtD
Disopyramide—Syncope—Pregabalin—epilepsy syndrome	4.57e-05	0.000375	CcSEcCtD
Disopyramide—Rash—Fosphenytoin—epilepsy syndrome	4.54e-05	0.000373	CcSEcCtD
Disopyramide—Dermatitis—Fosphenytoin—epilepsy syndrome	4.54e-05	0.000372	CcSEcCtD
Disopyramide—Nervousness—Gabapentin—epilepsy syndrome	4.54e-05	0.000372	CcSEcCtD
Disopyramide—Asthenia—Clonazepam—epilepsy syndrome	4.53e-05	0.000372	CcSEcCtD
Disopyramide—Headache—Fosphenytoin—epilepsy syndrome	4.52e-05	0.00037	CcSEcCtD
Disopyramide—Hepatitis—Topiramate—epilepsy syndrome	4.51e-05	0.00037	CcSEcCtD
Disopyramide—Thrombocytopenia—Valproic Acid—epilepsy syndrome	4.5e-05	0.000369	CcSEcCtD
Disopyramide—Asthenia—Phenytoin—epilepsy syndrome	4.5e-05	0.000369	CcSEcCtD
Disopyramide—Nausea—Midazolam—epilepsy syndrome	4.49e-05	0.000368	CcSEcCtD
Disopyramide—Hypoaesthesia—Topiramate—epilepsy syndrome	4.49e-05	0.000368	CcSEcCtD
Disopyramide—Diarrhoea—Zonisamide—epilepsy syndrome	4.48e-05	0.000368	CcSEcCtD
Disopyramide—Loss of consciousness—Pregabalin—epilepsy syndrome	4.48e-05	0.000367	CcSEcCtD
Disopyramide—Asthenia—Oxcarbazepine—epilepsy syndrome	4.48e-05	0.000367	CcSEcCtD
Disopyramide—Pruritus—Clonazepam—epilepsy syndrome	4.47e-05	0.000366	CcSEcCtD
Disopyramide—Vomiting—Vigabatrin—epilepsy syndrome	4.47e-05	0.000366	CcSEcCtD
Disopyramide—Skin disorder—Valproic Acid—epilepsy syndrome	4.47e-05	0.000366	CcSEcCtD
Disopyramide—Hyperhidrosis—Valproic Acid—epilepsy syndrome	4.45e-05	0.000365	CcSEcCtD
Disopyramide—Pruritus—Phenytoin—epilepsy syndrome	4.44e-05	0.000364	CcSEcCtD
Disopyramide—Nausea—Levetiracetam—epilepsy syndrome	4.44e-05	0.000364	CcSEcCtD
Disopyramide—Rash—Vigabatrin—epilepsy syndrome	4.43e-05	0.000363	CcSEcCtD
Disopyramide—Dizziness—Felbamate—epilepsy syndrome	4.43e-05	0.000363	CcSEcCtD
Disopyramide—Dermatitis—Vigabatrin—epilepsy syndrome	4.43e-05	0.000363	CcSEcCtD
Disopyramide—Pruritus—Oxcarbazepine—epilepsy syndrome	4.41e-05	0.000362	CcSEcCtD
Disopyramide—Vision blurred—Gabapentin—epilepsy syndrome	4.4e-05	0.000361	CcSEcCtD
Disopyramide—Headache—Vigabatrin—epilepsy syndrome	4.4e-05	0.000361	CcSEcCtD
Disopyramide—Vomiting—Diazepam—epilepsy syndrome	4.4e-05	0.000361	CcSEcCtD
Disopyramide—Anorexia—Valproic Acid—epilepsy syndrome	4.38e-05	0.000359	CcSEcCtD
Disopyramide—Rash—Diazepam—epilepsy syndrome	4.36e-05	0.000358	CcSEcCtD
Disopyramide—Dermatitis—Diazepam—epilepsy syndrome	4.36e-05	0.000357	CcSEcCtD
Disopyramide—Chest pain—Pregabalin—epilepsy syndrome	4.34e-05	0.000356	CcSEcCtD
Disopyramide—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.33e-05	0.000355	CcSEcCtD
Disopyramide—Dizziness—Zonisamide—epilepsy syndrome	4.33e-05	0.000355	CcSEcCtD
Disopyramide—Headache—Diazepam—epilepsy syndrome	4.33e-05	0.000355	CcSEcCtD
Disopyramide—Diarrhoea—Clonazepam—epilepsy syndrome	4.32e-05	0.000354	CcSEcCtD
Disopyramide—Hypotension—Valproic Acid—epilepsy syndrome	4.3e-05	0.000352	CcSEcCtD
Disopyramide—Asthenia—Carbamazepine—epilepsy syndrome	4.3e-05	0.000352	CcSEcCtD
Disopyramide—Diarrhoea—Phenytoin—epilepsy syndrome	4.29e-05	0.000352	CcSEcCtD
Disopyramide—Discomfort—Pregabalin—epilepsy syndrome	4.29e-05	0.000351	CcSEcCtD
Disopyramide—Nausea—Fosphenytoin—epilepsy syndrome	4.28e-05	0.000351	CcSEcCtD
Disopyramide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.27e-05	0.00035	CcSEcCtD
Disopyramide—Angioedema—Gabapentin—epilepsy syndrome	4.27e-05	0.00035	CcSEcCtD
Disopyramide—Vomiting—Felbamate—epilepsy syndrome	4.26e-05	0.000349	CcSEcCtD
Disopyramide—Dry mouth—Pregabalin—epilepsy syndrome	4.24e-05	0.000348	CcSEcCtD
Disopyramide—Pruritus—Carbamazepine—epilepsy syndrome	4.24e-05	0.000347	CcSEcCtD
Disopyramide—Rash—Felbamate—epilepsy syndrome	4.22e-05	0.000346	CcSEcCtD
Disopyramide—Dermatitis—Felbamate—epilepsy syndrome	4.22e-05	0.000346	CcSEcCtD
Disopyramide—Malaise—Gabapentin—epilepsy syndrome	4.21e-05	0.000345	CcSEcCtD
Disopyramide—Vertigo—Gabapentin—epilepsy syndrome	4.2e-05	0.000344	CcSEcCtD
Disopyramide—Headache—Felbamate—epilepsy syndrome	4.19e-05	0.000344	CcSEcCtD
Disopyramide—Confusional state—Pregabalin—epilepsy syndrome	4.19e-05	0.000344	CcSEcCtD
Disopyramide—Syncope—Gabapentin—epilepsy syndrome	4.19e-05	0.000343	CcSEcCtD
Disopyramide—Dizziness—Clonazepam—epilepsy syndrome	4.18e-05	0.000342	CcSEcCtD
Disopyramide—Nausea—Vigabatrin—epilepsy syndrome	4.17e-05	0.000342	CcSEcCtD
Disopyramide—Vomiting—Zonisamide—epilepsy syndrome	4.17e-05	0.000342	CcSEcCtD
Disopyramide—Insomnia—Valproic Acid—epilepsy syndrome	4.16e-05	0.000341	CcSEcCtD
Disopyramide—Oedema—Pregabalin—epilepsy syndrome	4.16e-05	0.000341	CcSEcCtD
Disopyramide—Asthenia—Lamotrigine—epilepsy syndrome	4.15e-05	0.00034	CcSEcCtD
Disopyramide—Dizziness—Phenytoin—epilepsy syndrome	4.15e-05	0.00034	CcSEcCtD
Disopyramide—Rash—Zonisamide—epilepsy syndrome	4.13e-05	0.000339	CcSEcCtD
Disopyramide—Paraesthesia—Valproic Acid—epilepsy syndrome	4.13e-05	0.000339	CcSEcCtD
Disopyramide—Dermatitis—Zonisamide—epilepsy syndrome	4.13e-05	0.000338	CcSEcCtD
Disopyramide—Dizziness—Oxcarbazepine—epilepsy syndrome	4.13e-05	0.000338	CcSEcCtD
Disopyramide—Nausea—Diazepam—epilepsy syndrome	4.11e-05	0.000337	CcSEcCtD
Disopyramide—Loss of consciousness—Gabapentin—epilepsy syndrome	4.11e-05	0.000337	CcSEcCtD
Disopyramide—Headache—Zonisamide—epilepsy syndrome	4.11e-05	0.000337	CcSEcCtD
Disopyramide—Dyspnoea—Valproic Acid—epilepsy syndrome	4.1e-05	0.000336	CcSEcCtD
Disopyramide—Diarrhoea—Carbamazepine—epilepsy syndrome	4.1e-05	0.000336	CcSEcCtD
Disopyramide—Pruritus—Lamotrigine—epilepsy syndrome	4.09e-05	0.000336	CcSEcCtD
Disopyramide—Shock—Pregabalin—epilepsy syndrome	4.09e-05	0.000335	CcSEcCtD
Disopyramide—Somnolence—Valproic Acid—epilepsy syndrome	4.09e-05	0.000335	CcSEcCtD
Disopyramide—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.07e-05	0.000334	CcSEcCtD
Disopyramide—Dyspepsia—Valproic Acid—epilepsy syndrome	4.05e-05	0.000332	CcSEcCtD
Disopyramide—Skin disorder—Pregabalin—epilepsy syndrome	4.04e-05	0.000331	CcSEcCtD
Disopyramide—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.02e-05	0.00033	CcSEcCtD
Disopyramide—Vomiting—Clonazepam—epilepsy syndrome	4.02e-05	0.000329	CcSEcCtD
Disopyramide—Decreased appetite—Valproic Acid—epilepsy syndrome	4e-05	0.000328	CcSEcCtD
Disopyramide—Vomiting—Phenytoin—epilepsy syndrome	3.99e-05	0.000327	CcSEcCtD
Disopyramide—Rash—Clonazepam—epilepsy syndrome	3.98e-05	0.000326	CcSEcCtD
Disopyramide—Dermatitis—Clonazepam—epilepsy syndrome	3.98e-05	0.000326	CcSEcCtD
Disopyramide—Chest pain—Gabapentin—epilepsy syndrome	3.98e-05	0.000326	CcSEcCtD
Disopyramide—Nausea—Felbamate—epilepsy syndrome	3.98e-05	0.000326	CcSEcCtD
Disopyramide—Vomiting—Oxcarbazepine—epilepsy syndrome	3.97e-05	0.000325	CcSEcCtD
Disopyramide—Fatigue—Valproic Acid—epilepsy syndrome	3.96e-05	0.000325	CcSEcCtD
Disopyramide—Anorexia—Pregabalin—epilepsy syndrome	3.96e-05	0.000325	CcSEcCtD
Disopyramide—Dizziness—Carbamazepine—epilepsy syndrome	3.96e-05	0.000325	CcSEcCtD
Disopyramide—Diarrhoea—Lamotrigine—epilepsy syndrome	3.96e-05	0.000325	CcSEcCtD
Disopyramide—Headache—Clonazepam—epilepsy syndrome	3.96e-05	0.000324	CcSEcCtD
Disopyramide—Rash—Phenytoin—epilepsy syndrome	3.96e-05	0.000324	CcSEcCtD
Disopyramide—Dermatitis—Phenytoin—epilepsy syndrome	3.95e-05	0.000324	CcSEcCtD
Disopyramide—Rash—Oxcarbazepine—epilepsy syndrome	3.93e-05	0.000323	CcSEcCtD
Disopyramide—Pain—Valproic Acid—epilepsy syndrome	3.93e-05	0.000322	CcSEcCtD
Disopyramide—Constipation—Valproic Acid—epilepsy syndrome	3.93e-05	0.000322	CcSEcCtD
Disopyramide—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.93e-05	0.000322	CcSEcCtD
Disopyramide—Headache—Phenytoin—epilepsy syndrome	3.93e-05	0.000322	CcSEcCtD
Disopyramide—Discomfort—Gabapentin—epilepsy syndrome	3.93e-05	0.000322	CcSEcCtD
Disopyramide—Headache—Oxcarbazepine—epilepsy syndrome	3.91e-05	0.000321	CcSEcCtD
Disopyramide—Nausea—Zonisamide—epilepsy syndrome	3.89e-05	0.000319	CcSEcCtD
Disopyramide—Dry mouth—Gabapentin—epilepsy syndrome	3.89e-05	0.000319	CcSEcCtD
Disopyramide—Hypotension—Pregabalin—epilepsy syndrome	3.89e-05	0.000319	CcSEcCtD
Disopyramide—Flatulence—Topiramate—epilepsy syndrome	3.87e-05	0.000318	CcSEcCtD
Disopyramide—Tension—Topiramate—epilepsy syndrome	3.86e-05	0.000316	CcSEcCtD
Disopyramide—Dysgeusia—Topiramate—epilepsy syndrome	3.85e-05	0.000316	CcSEcCtD
Disopyramide—Confusional state—Gabapentin—epilepsy syndrome	3.84e-05	0.000315	CcSEcCtD
Disopyramide—Dizziness—Lamotrigine—epilepsy syndrome	3.83e-05	0.000314	CcSEcCtD
Disopyramide—Nervousness—Topiramate—epilepsy syndrome	3.82e-05	0.000313	CcSEcCtD
Disopyramide—Oedema—Gabapentin—epilepsy syndrome	3.81e-05	0.000313	CcSEcCtD
Disopyramide—Vomiting—Carbamazepine—epilepsy syndrome	3.81e-05	0.000312	CcSEcCtD
Disopyramide—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.79e-05	0.000311	CcSEcCtD
Disopyramide—Rash—Carbamazepine—epilepsy syndrome	3.78e-05	0.00031	CcSEcCtD
Disopyramide—Dermatitis—Carbamazepine—epilepsy syndrome	3.77e-05	0.000309	CcSEcCtD
Disopyramide—Insomnia—Pregabalin—epilepsy syndrome	3.76e-05	0.000308	CcSEcCtD
Disopyramide—Nausea—Clonazepam—epilepsy syndrome	3.75e-05	0.000308	CcSEcCtD
Disopyramide—Headache—Carbamazepine—epilepsy syndrome	3.75e-05	0.000308	CcSEcCtD
Disopyramide—Shock—Gabapentin—epilepsy syndrome	3.75e-05	0.000308	CcSEcCtD
Disopyramide—Paraesthesia—Pregabalin—epilepsy syndrome	3.73e-05	0.000306	CcSEcCtD
Disopyramide—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.73e-05	0.000306	CcSEcCtD
Disopyramide—Nausea—Phenytoin—epilepsy syndrome	3.73e-05	0.000306	CcSEcCtD
Disopyramide—Dyspnoea—Pregabalin—epilepsy syndrome	3.71e-05	0.000304	CcSEcCtD
Disopyramide—Nausea—Oxcarbazepine—epilepsy syndrome	3.71e-05	0.000304	CcSEcCtD
Disopyramide—Vision blurred—Topiramate—epilepsy syndrome	3.7e-05	0.000304	CcSEcCtD
Disopyramide—Skin disorder—Gabapentin—epilepsy syndrome	3.7e-05	0.000304	CcSEcCtD
Disopyramide—Somnolence—Pregabalin—epilepsy syndrome	3.7e-05	0.000303	CcSEcCtD
Disopyramide—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.69e-05	0.000302	CcSEcCtD
Disopyramide—Vomiting—Lamotrigine—epilepsy syndrome	3.68e-05	0.000302	CcSEcCtD
Disopyramide—Urticaria—Valproic Acid—epilepsy syndrome	3.65e-05	0.0003	CcSEcCtD
Disopyramide—Rash—Lamotrigine—epilepsy syndrome	3.65e-05	0.000299	CcSEcCtD
Disopyramide—Ill-defined disorder—Topiramate—epilepsy syndrome	3.65e-05	0.000299	CcSEcCtD
Disopyramide—Dermatitis—Lamotrigine—epilepsy syndrome	3.65e-05	0.000299	CcSEcCtD
Disopyramide—Body temperature increased—Valproic Acid—epilepsy syndrome	3.64e-05	0.000298	CcSEcCtD
Disopyramide—Anorexia—Gabapentin—epilepsy syndrome	3.63e-05	0.000298	CcSEcCtD
Disopyramide—Headache—Lamotrigine—epilepsy syndrome	3.63e-05	0.000297	CcSEcCtD
Disopyramide—Decreased appetite—Pregabalin—epilepsy syndrome	3.61e-05	0.000296	CcSEcCtD
Disopyramide—Fatigue—Pregabalin—epilepsy syndrome	3.58e-05	0.000294	CcSEcCtD
Disopyramide—Hypotension—Gabapentin—epilepsy syndrome	3.56e-05	0.000292	CcSEcCtD
Disopyramide—Nausea—Carbamazepine—epilepsy syndrome	3.56e-05	0.000292	CcSEcCtD
Disopyramide—Pain—Pregabalin—epilepsy syndrome	3.56e-05	0.000292	CcSEcCtD
Disopyramide—Constipation—Pregabalin—epilepsy syndrome	3.56e-05	0.000292	CcSEcCtD
Disopyramide—Malaise—Topiramate—epilepsy syndrome	3.54e-05	0.000291	CcSEcCtD
Disopyramide—Vertigo—Topiramate—epilepsy syndrome	3.53e-05	0.00029	CcSEcCtD
Disopyramide—Syncope—Topiramate—epilepsy syndrome	3.52e-05	0.000289	CcSEcCtD
Disopyramide—Dextropropoxyphene—CYP2D6—epilepsy syndrome	3.46e-05	0.0114	CrCbGaD
Disopyramide—Loss of consciousness—Topiramate—epilepsy syndrome	3.45e-05	0.000283	CcSEcCtD
Disopyramide—Insomnia—Gabapentin—epilepsy syndrome	3.45e-05	0.000283	CcSEcCtD
Disopyramide—Nausea—Lamotrigine—epilepsy syndrome	3.44e-05	0.000282	CcSEcCtD
Disopyramide—Feeling abnormal—Pregabalin—epilepsy syndrome	3.43e-05	0.000281	CcSEcCtD
Disopyramide—Paraesthesia—Gabapentin—epilepsy syndrome	3.42e-05	0.000281	CcSEcCtD
Disopyramide—Dyspnoea—Gabapentin—epilepsy syndrome	3.4e-05	0.000279	CcSEcCtD
Disopyramide—Somnolence—Gabapentin—epilepsy syndrome	3.39e-05	0.000278	CcSEcCtD
Disopyramide—Dyspepsia—Gabapentin—epilepsy syndrome	3.36e-05	0.000275	CcSEcCtD
Disopyramide—Chest pain—Topiramate—epilepsy syndrome	3.35e-05	0.000274	CcSEcCtD
Disopyramide—Decreased appetite—Gabapentin—epilepsy syndrome	3.31e-05	0.000272	CcSEcCtD
Disopyramide—Discomfort—Topiramate—epilepsy syndrome	3.31e-05	0.000271	CcSEcCtD
Disopyramide—Urticaria—Pregabalin—epilepsy syndrome	3.3e-05	0.000271	CcSEcCtD
Disopyramide—Asthenia—Valproic Acid—epilepsy syndrome	3.3e-05	0.000271	CcSEcCtD
Disopyramide—Fatigue—Gabapentin—epilepsy syndrome	3.29e-05	0.000269	CcSEcCtD
Disopyramide—Body temperature increased—Pregabalin—epilepsy syndrome	3.29e-05	0.000269	CcSEcCtD
Disopyramide—Dry mouth—Topiramate—epilepsy syndrome	3.27e-05	0.000268	CcSEcCtD
Disopyramide—Pain—Gabapentin—epilepsy syndrome	3.26e-05	0.000267	CcSEcCtD
Disopyramide—Constipation—Gabapentin—epilepsy syndrome	3.26e-05	0.000267	CcSEcCtD
Disopyramide—Pruritus—Valproic Acid—epilepsy syndrome	3.25e-05	0.000267	CcSEcCtD
Disopyramide—Confusional state—Topiramate—epilepsy syndrome	3.23e-05	0.000265	CcSEcCtD
Disopyramide—Oedema—Topiramate—epilepsy syndrome	3.21e-05	0.000263	CcSEcCtD
Disopyramide—Methadone—CYP2C19—epilepsy syndrome	3.16e-05	0.0104	CrCbGaD
Disopyramide—Shock—Topiramate—epilepsy syndrome	3.16e-05	0.000259	CcSEcCtD
Disopyramide—Diarrhoea—Valproic Acid—epilepsy syndrome	3.15e-05	0.000258	CcSEcCtD
Disopyramide—Feeling abnormal—Gabapentin—epilepsy syndrome	3.14e-05	0.000258	CcSEcCtD
Disopyramide—Thrombocytopenia—Topiramate—epilepsy syndrome	3.14e-05	0.000257	CcSEcCtD
Disopyramide—Skin disorder—Topiramate—epilepsy syndrome	3.12e-05	0.000255	CcSEcCtD
Disopyramide—Hyperhidrosis—Topiramate—epilepsy syndrome	3.1e-05	0.000254	CcSEcCtD
Disopyramide—Anorexia—Topiramate—epilepsy syndrome	3.06e-05	0.000251	CcSEcCtD
Disopyramide—Dizziness—Valproic Acid—epilepsy syndrome	3.04e-05	0.000249	CcSEcCtD
Disopyramide—Urticaria—Gabapentin—epilepsy syndrome	3.03e-05	0.000248	CcSEcCtD
Disopyramide—Body temperature increased—Gabapentin—epilepsy syndrome	3.01e-05	0.000247	CcSEcCtD
Disopyramide—Hypotension—Topiramate—epilepsy syndrome	3e-05	0.000246	CcSEcCtD
Disopyramide—Asthenia—Pregabalin—epilepsy syndrome	2.98e-05	0.000245	CcSEcCtD
Disopyramide—Pruritus—Pregabalin—epilepsy syndrome	2.94e-05	0.000241	CcSEcCtD
Disopyramide—Vomiting—Valproic Acid—epilepsy syndrome	2.92e-05	0.00024	CcSEcCtD
Disopyramide—Insomnia—Topiramate—epilepsy syndrome	2.9e-05	0.000238	CcSEcCtD
Disopyramide—Rash—Valproic Acid—epilepsy syndrome	2.9e-05	0.000238	CcSEcCtD
Disopyramide—Dermatitis—Valproic Acid—epilepsy syndrome	2.9e-05	0.000238	CcSEcCtD
Disopyramide—Headache—Valproic Acid—epilepsy syndrome	2.88e-05	0.000236	CcSEcCtD
Disopyramide—Paraesthesia—Topiramate—epilepsy syndrome	2.88e-05	0.000236	CcSEcCtD
Disopyramide—Dyspnoea—Topiramate—epilepsy syndrome	2.86e-05	0.000234	CcSEcCtD
Disopyramide—Somnolence—Topiramate—epilepsy syndrome	2.85e-05	0.000234	CcSEcCtD
Disopyramide—Diarrhoea—Pregabalin—epilepsy syndrome	2.84e-05	0.000233	CcSEcCtD
Disopyramide—Dyspepsia—Topiramate—epilepsy syndrome	2.82e-05	0.000231	CcSEcCtD
Disopyramide—Decreased appetite—Topiramate—epilepsy syndrome	2.79e-05	0.000229	CcSEcCtD
Disopyramide—Fatigue—Topiramate—epilepsy syndrome	2.77e-05	0.000227	CcSEcCtD
Disopyramide—Dizziness—Pregabalin—epilepsy syndrome	2.75e-05	0.000225	CcSEcCtD
Disopyramide—Pain—Topiramate—epilepsy syndrome	2.74e-05	0.000225	CcSEcCtD
Disopyramide—Constipation—Topiramate—epilepsy syndrome	2.74e-05	0.000225	CcSEcCtD
Disopyramide—Asthenia—Gabapentin—epilepsy syndrome	2.74e-05	0.000224	CcSEcCtD
Disopyramide—Nausea—Valproic Acid—epilepsy syndrome	2.73e-05	0.000224	CcSEcCtD
Disopyramide—Pruritus—Gabapentin—epilepsy syndrome	2.7e-05	0.000221	CcSEcCtD
Disopyramide—Vomiting—Pregabalin—epilepsy syndrome	2.64e-05	0.000217	CcSEcCtD
Disopyramide—Feeling abnormal—Topiramate—epilepsy syndrome	2.64e-05	0.000217	CcSEcCtD
Disopyramide—Rash—Pregabalin—epilepsy syndrome	2.62e-05	0.000215	CcSEcCtD
Disopyramide—Dermatitis—Pregabalin—epilepsy syndrome	2.62e-05	0.000215	CcSEcCtD
Disopyramide—Diarrhoea—Gabapentin—epilepsy syndrome	2.61e-05	0.000214	CcSEcCtD
Disopyramide—Headache—Pregabalin—epilepsy syndrome	2.6e-05	0.000214	CcSEcCtD
Disopyramide—Urticaria—Topiramate—epilepsy syndrome	2.55e-05	0.000209	CcSEcCtD
Disopyramide—Body temperature increased—Topiramate—epilepsy syndrome	2.54e-05	0.000208	CcSEcCtD
Disopyramide—Dizziness—Gabapentin—epilepsy syndrome	2.52e-05	0.000207	CcSEcCtD
Disopyramide—Nausea—Pregabalin—epilepsy syndrome	2.47e-05	0.000202	CcSEcCtD
Disopyramide—Vomiting—Gabapentin—epilepsy syndrome	2.42e-05	0.000199	CcSEcCtD
Disopyramide—Rash—Gabapentin—epilepsy syndrome	2.4e-05	0.000197	CcSEcCtD
Disopyramide—Dermatitis—Gabapentin—epilepsy syndrome	2.4e-05	0.000197	CcSEcCtD
Disopyramide—Headache—Gabapentin—epilepsy syndrome	2.39e-05	0.000196	CcSEcCtD
Disopyramide—Methadone—CYP2D6—epilepsy syndrome	2.34e-05	0.00771	CrCbGaD
Disopyramide—Asthenia—Topiramate—epilepsy syndrome	2.3e-05	0.000189	CcSEcCtD
Disopyramide—Pruritus—Topiramate—epilepsy syndrome	2.27e-05	0.000186	CcSEcCtD
Disopyramide—Nausea—Gabapentin—epilepsy syndrome	2.26e-05	0.000186	CcSEcCtD
Disopyramide—Diarrhoea—Topiramate—epilepsy syndrome	2.19e-05	0.00018	CcSEcCtD
Disopyramide—Dizziness—Topiramate—epilepsy syndrome	2.12e-05	0.000174	CcSEcCtD
Disopyramide—Vomiting—Topiramate—epilepsy syndrome	2.04e-05	0.000167	CcSEcCtD
Disopyramide—Rash—Topiramate—epilepsy syndrome	2.02e-05	0.000166	CcSEcCtD
Disopyramide—Dermatitis—Topiramate—epilepsy syndrome	2.02e-05	0.000166	CcSEcCtD
Disopyramide—Headache—Topiramate—epilepsy syndrome	2.01e-05	0.000165	CcSEcCtD
Disopyramide—Nausea—Topiramate—epilepsy syndrome	1.91e-05	0.000156	CcSEcCtD
Disopyramide—Methadone—ABCB1—epilepsy syndrome	1.67e-05	0.0055	CrCbGaD
Disopyramide—CHRM3—Signaling Pathways—OXT—epilepsy syndrome	2.68e-06	3.04e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CRH—epilepsy syndrome	2.68e-06	3.04e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCL3—epilepsy syndrome	2.68e-06	3.04e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CXCL2—epilepsy syndrome	2.68e-06	3.04e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HSPB1—epilepsy syndrome	2.68e-06	3.04e-05	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	2.67e-06	3.04e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PLCB1—epilepsy syndrome	2.66e-06	3.03e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—TH—epilepsy syndrome	2.65e-06	3.01e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	2.65e-06	3.01e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	2.65e-06	3.01e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	2.65e-06	3.01e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	2.65e-06	3.01e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	2.65e-06	3.01e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	2.65e-06	3.01e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	2.64e-06	3e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	2.62e-06	2.98e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	2.61e-06	2.97e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	2.59e-06	2.95e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	2.58e-06	2.94e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—HMOX1—epilepsy syndrome	2.57e-06	2.92e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	2.56e-06	2.91e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—CAT—epilepsy syndrome	2.54e-06	2.88e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	2.53e-06	2.88e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	2.53e-06	2.88e-05	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.5e-06	2.84e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	2.5e-06	2.84e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	2.5e-06	2.84e-05	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.49e-06	2.84e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	2.49e-06	2.83e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	2.49e-06	2.83e-05	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.47e-06	2.81e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ABCB1—epilepsy syndrome	2.47e-06	2.8e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	2.46e-06	2.8e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	2.46e-06	2.8e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	2.46e-06	2.8e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	2.45e-06	2.79e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	2.43e-06	2.76e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	2.43e-06	2.76e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SST—epilepsy syndrome	2.43e-06	2.76e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	2.43e-06	2.76e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	2.42e-06	2.75e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SST—epilepsy syndrome	2.42e-06	2.75e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	2.42e-06	2.75e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	2.41e-06	2.74e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	2.4e-06	2.73e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	2.4e-06	2.72e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	2.4e-06	2.72e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SST—epilepsy syndrome	2.4e-06	2.72e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—HMOX1—epilepsy syndrome	2.4e-06	2.72e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.38e-06	2.71e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	2.38e-06	2.7e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	2.38e-06	2.7e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	2.37e-06	2.69e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	2.37e-06	2.69e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—CAT—epilepsy syndrome	2.36e-06	2.69e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	2.36e-06	2.68e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	2.35e-06	2.67e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	2.34e-06	2.66e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.32e-06	2.63e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ABCB1—epilepsy syndrome	2.3e-06	2.61e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—GPX1—epilepsy syndrome	2.29e-06	2.61e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	2.28e-06	2.59e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	2.28e-06	2.59e-05	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	2.28e-06	2.59e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	2.28e-06	2.59e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	2.28e-06	2.59e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	2.27e-06	2.58e-05	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	2.27e-06	2.58e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	2.26e-06	2.57e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	2.26e-06	2.57e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.26e-06	2.57e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.26e-06	2.57e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	2.26e-06	2.56e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	2.25e-06	2.56e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	2.25e-06	2.56e-05	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	2.25e-06	2.56e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	2.24e-06	2.55e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	2.24e-06	2.55e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	2.24e-06	2.55e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	2.23e-06	2.54e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	2.23e-06	2.54e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	2.23e-06	2.54e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	2.23e-06	2.54e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	2.23e-06	2.53e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—HMOX1—epilepsy syndrome	2.21e-06	2.52e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	2.21e-06	2.51e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	2.21e-06	2.51e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	2.2e-06	2.51e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	2.19e-06	2.49e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—CAT—epilepsy syndrome	2.18e-06	2.48e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	2.18e-06	2.48e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	2.16e-06	2.45e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.15e-06	2.45e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.15e-06	2.45e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—GPX1—epilepsy syndrome	2.14e-06	2.43e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ABCB1—epilepsy syndrome	2.12e-06	2.42e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	2.12e-06	2.41e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	2.12e-06	2.4e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.11e-06	2.4e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	2.09e-06	2.38e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	2.08e-06	2.37e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	2.08e-06	2.36e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	2.07e-06	2.35e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.06e-06	2.35e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	2.06e-06	2.35e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	2.06e-06	2.34e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	2.04e-06	2.32e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	2.03e-06	2.31e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	2.03e-06	2.31e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	2.03e-06	2.3e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.02e-06	2.3e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	2.02e-06	2.29e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—AGT—epilepsy syndrome	2.01e-06	2.29e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	2.01e-06	2.28e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	2e-06	2.27e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	1.99e-06	2.26e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—GPX1—epilepsy syndrome	1.97e-06	2.25e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—APOE—epilepsy syndrome	1.97e-06	2.24e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	1.92e-06	2.19e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	1.92e-06	2.18e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	1.91e-06	2.17e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	1.9e-06	2.16e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	1.9e-06	2.16e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	1.9e-06	2.16e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	1.89e-06	2.15e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	1.88e-06	2.14e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	1.88e-06	2.13e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—AGT—epilepsy syndrome	1.87e-06	2.13e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	1.86e-06	2.11e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	1.84e-06	2.09e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—APOE—epilepsy syndrome	1.84e-06	2.09e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	1.83e-06	2.09e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	1.82e-06	2.06e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	1.8e-06	2.05e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	1.74e-06	1.98e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	1.73e-06	1.97e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—AGT—epilepsy syndrome	1.73e-06	1.97e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	1.72e-06	1.95e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—APOE—epilepsy syndrome	1.7e-06	1.93e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—POMC—epilepsy syndrome	1.69e-06	1.92e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	1.69e-06	1.92e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	1.69e-06	1.92e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	1.69e-06	1.92e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	1.68e-06	1.91e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	1.68e-06	1.91e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	1.68e-06	1.91e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	1.67e-06	1.9e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	1.66e-06	1.89e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	1.66e-06	1.89e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	1.63e-06	1.86e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	1.63e-06	1.86e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.63e-06	1.85e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	1.62e-06	1.84e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	1.61e-06	1.83e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.61e-06	1.83e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	1.6e-06	1.82e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	1.59e-06	1.8e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—POMC—epilepsy syndrome	1.58e-06	1.79e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	1.56e-06	1.78e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	1.56e-06	1.77e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	1.54e-06	1.76e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—ALB—epilepsy syndrome	1.54e-06	1.75e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	1.53e-06	1.74e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	1.53e-06	1.73e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	1.51e-06	1.72e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—POMC—epilepsy syndrome	1.46e-06	1.66e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	1.45e-06	1.65e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	1.45e-06	1.65e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	1.45e-06	1.65e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	1.45e-06	1.65e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—ALB—epilepsy syndrome	1.44e-06	1.64e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	1.44e-06	1.63e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	1.43e-06	1.63e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	1.42e-06	1.62e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	1.42e-06	1.61e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	1.4e-06	1.6e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	1.39e-06	1.59e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	1.39e-06	1.58e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	1.38e-06	1.56e-05	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	1.35e-06	1.54e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	1.34e-06	1.53e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	1.34e-06	1.52e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	1.34e-06	1.52e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	1.33e-06	1.51e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.33e-06	1.51e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—ALB—epilepsy syndrome	1.33e-06	1.51e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	1.32e-06	1.51e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	1.32e-06	1.5e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.3e-06	1.47e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.29e-06	1.47e-05	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	1.26e-06	1.43e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	1.22e-06	1.39e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	1.22e-06	1.39e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	1.21e-06	1.37e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	1.2e-06	1.36e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	1.19e-06	1.36e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	1.18e-06	1.34e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.16e-06	1.32e-05	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—PTGS2—epilepsy syndrome	1.16e-06	1.32e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.11e-06	1.26e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.1e-06	1.25e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	1.08e-06	1.23e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	1.08e-06	1.23e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	1.07e-06	1.21e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.05e-06	1.2e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.04e-06	1.18e-05	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—TH—epilepsy syndrome	1.04e-06	1.18e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	1e-06	1.14e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	1e-06	1.14e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	9.91e-07	1.13e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	9.84e-07	1.12e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	9.81e-07	1.12e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	9.72e-07	1.1e-05	CbGpPWpGaD
Disopyramide—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	9.14e-07	1.04e-05	CbGpPWpGaD
Disopyramide—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	9.11e-07	1.04e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	9.05e-07	1.03e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	9.02e-07	1.03e-05	CbGpPWpGaD
Disopyramide—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	9.02e-07	1.03e-05	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	8.94e-07	1.02e-05	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	8.79e-07	1e-05	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	8.76e-07	9.96e-06	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	8.68e-07	9.87e-06	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	8.65e-07	9.84e-06	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	8.55e-07	9.73e-06	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—CAT—epilepsy syndrome	8.54e-07	9.71e-06	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	8.53e-07	9.69e-06	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	8.44e-07	9.6e-06	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	8.3e-07	9.44e-06	CbGpPWpGaD
Disopyramide—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	8.3e-07	9.43e-06	CbGpPWpGaD
Disopyramide—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	8.27e-07	9.4e-06	CbGpPWpGaD
Disopyramide—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	8.19e-07	9.31e-06	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	7.89e-07	8.97e-06	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	7.86e-07	8.94e-06	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	7.79e-07	8.85e-06	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	7.72e-07	8.78e-06	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	7.68e-07	8.73e-06	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	7.66e-07	8.71e-06	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	7.58e-07	8.62e-06	CbGpPWpGaD
Disopyramide—SLC22A2—Metabolism—AKT1—epilepsy syndrome	6.79e-07	7.72e-06	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AGT—epilepsy syndrome	6.77e-07	7.7e-06	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—APOE—epilepsy syndrome	6.63e-07	7.54e-06	CbGpPWpGaD
Disopyramide—SLC22A1—Metabolism—AKT1—epilepsy syndrome	6.33e-07	7.19e-06	CbGpPWpGaD
Disopyramide—CHRM3—Metabolism—AKT1—epilepsy syndrome	5.84e-07	6.64e-06	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—POMC—epilepsy syndrome	5.7e-07	6.48e-06	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—ALB—epilepsy syndrome	5.19e-07	5.91e-06	CbGpPWpGaD
Disopyramide—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	4.9e-07	5.57e-06	CbGpPWpGaD
Disopyramide—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	4.89e-07	5.55e-06	CbGpPWpGaD
Disopyramide—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	4.84e-07	5.5e-06	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	4.54e-07	5.17e-06	CbGpPWpGaD
Disopyramide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.28e-07	2.6e-06	CbGpPWpGaD
